top of page
Lo, Amy Cheuk Yin.jpg

Professor Amy C.Y.  Lo
勞卓妍教授

Associate Professor 副教授

 

B.S. (Distinction) (University of Hawaii at Manoa, Chemistry)

Ph.D. (Johns Hopkins University School of Medicine, Neuroscience)

Phone 電話

(852) 2831 5363

Email 電郵

amylo@hku.hk

The HKU Scholars Hub 香港大學學術庫

HKU Scholars Hub

ORCID

0000-0003-4239-6851

Research Gate

Research Gate

Research 研究

My primary research focus is on neuroprotection in retinal and cerebral ischemic injury. We aim to develop and use animal models for understanding the underlying mechanisms of retinal and cerebral ischemic injury as well as providing a platform for screening of various pharmacological and natural agents, with a long-term goal of developing new therapeutic targets and novel neuroprotective agents of clinical efficacy in the treatment of ischemic retinopathy and cerebral ischemia.

The current research focus includes:

  1. Neuroprotection in retinal degenerative diseases – biology and therapeutics

  2. Ocular angiogenesis – disease, mechanisms and therapeutics

  3. Bioengineering – intraocular drug delivery and intraocular tamponades

  4. Pathogenesis of stroke using various transgenic and knockout mouse model

我的主要研究重點是視網膜和腦缺血損傷的神經保護。我們的目標是開發和使用動物模型來了解視網膜和腦缺血損傷的潛在機制，並提供一個篩選各種藥理和天然藥物的平台，長期目標是開發新的治療靶點和新型神經保護劑。治療缺血性視網膜病變和腦缺血的臨床療效。

目前的研究重點包括：

  1. 視網膜退行性疾病的神經保護——生物學和治療學

  2. 眼部血管生成——疾病、機制和治療

  3. 生物工程——眼內給藥和眼內填塞

  4. 使用各種轉基因和基因敲除小鼠模型研究中風的發病機制

Services 服務

Local 本地

Co-Chairman:

  • 9th International Symposium on Healthy Aging (2014)

  • Physiology Symposium 2014 & Joint Scientific Conference of The Hong Kong Society of Neurosciences & The Biophysical Society of Hong Kong (2014)

  • 10th International Symposium on Healthy Aging (2015)

 

Organizing Committee:

  • Joint Scientific Conference of The Hong Kong Society of Neurosciences & The Biophysical Society of Hong Kong (2012)

  • 11th International Symposium on Healthy Aging (2016)

  • Neuroscience Symposium 2016 Annual Scientific Conference of The Hong Kong Society of Neurosciences (2016)

  • 12th International Symposium on Healthy Aging (2017)

  • 13th International Symposium on Healthy Aging (2018)

  • 14th International Symposium on Healthy Aging (2019)

  • 15th International Symposium on Healthy Aging (2021)

  • 16th International Symposium on Healthy Aging (2022)

 

Group Facilitator, Responsible Conduct of Research (RCR) Seminar, HKU

Moderator, Research Integrity for Graduate Students, HKU

Faculty Academic Advisor, LKS Faculty of Medicine, HKU

Preceptorship for MBBS Students, LKS Faculty of Medicine, HKU

Problem-Based Learning (PBL) Educator, LKS Faculty of Medicine, HKU

Equal Opportunity Advisor, Department of Ophthalmology, HKU

​

International 海外

  • Young Investigator Committee, International Society for Eye Research (ISER)

  • Women in Eye and Vision Research (WEAVR) Networking Committee, The Association for Research in Vision and Ophthalmology (ARVO)

  • Women in Eye and Vision Research (WEAVR) Leadership Committee, The Association for Research in Vision and Ophthalmology (ARVO)

  • Mentor, The Association for Research in Vision and Ophthalmology (ARVO) Global Mentorship Program

  • Member, The Association for Research in Vision and Ophthalmology (ARVO) Animals in Research Committee (ARC)

Teaching 教學

Primary supervisor：

   Graduated -  9 PhD, 2 MPhil and 2 MRes[Med] students

   Current - 5 PhD, 1 MRes[Med]

Co-supervisor :

   Graduated -  7 PhD, 2 MPhil and 4 MRes[Med] students

   Current -  1 PhD, 4 MRes[Med]

​

External Examiner for 8 PhD theses - Macau University of Science and Technology, The Chinese University of Hong Kong, The Hong Kong Polytechnic University
Internal Examiner for 31 PhD, 5 MPhil and 2 MMedSc theses – The University of Hong Kong
Thesis Examination Committee Chairman for 15 PhD and 6 MPhil theses – The University of Hong Kong

Publication Records 文獻記錄

109 journal articles/reviews
9 book chapters
24 invited talks and oral presentations
225 conference abstract

Selected Refereed Publications 參考文獻

(*Corresponding Authors 通訊作者)

  1. Wong FSY*, Tsang KK, Chan BP, Lo ACY*. Both non-coated and polyelectrolytically-coated intraocular collagen-alginate composite gels enhanced photoreceptor survival in retinal degeneration. Biomaterials. 2023 Feb;293:121948. doi: 10.1016/j.biomaterials.2022.121948. Epub 2022 Dec 6.PMID: 36516686

  2. Liu J, Tsang JKW, Fung FKC, Chung SK, Fu Z*, Lo ACY*. Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity. Front Pharmacol. 2022 Aug 17;13:945130. doi: 10.3389/fphar.2022.945130. eCollection 2022.PMID: 36059936

  3. Lo ACY*, Yang M. Lycium barbarum polysaccharides and ferroptosis: jumping into the era of novel regulated cell death. Neural Regen Res. 2022 Jul;17(7):1473-1474. doi: 10.4103/1673-5374.330600. PMID: 34916422

  4. Lai AKW, Ng TC, Hung VKL, Tam KC, Cheung CW, Chung SK, Lo ACY*. Exacerbated VEGF up-regulation accompanies diabetes-aggravated hemorrhage in mice after experimental cerebral ischemia and delayed reperfusion. Neural Regen Res. 2022 Jul;17(7):1566-1575. doi: 10.4103/1673-5374.330612. PMID: 34916442

  5. Wang Y, Fung NSK, Lam WC, Lo ACY*. mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases. Antioxidants (Basel). 2022 Jun 29;11(7):1304. doi: 10.3390/antiox11071304.PMID: 35883796

  6. Yang M, Tsui MG, Tsang JKW, Goit RK, Yao KM, So KF*, Lam WC*, Lo ACY*. Involvement of FSP1-CoQ10-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis. Cell Death Dis. 2022 May 18;13(5):468. doi: 10.1038/s41419-022-04924-4. PMID: 35585057 

  7. Goit RK, Taylor AW, Lo ACY*. The central melanocortin system as a treatment target for obesity and diabetes: A brief overview. Eur J Pharmacol. 2022 Jun 5;924:174956. doi: 10.1016/j.ejphar.2022.174956. Epub 2022 Apr 14. PMID: 35430211

  8. Goit RK, Taylor AW, Lo ACY*. Anti-inflammatory α-Melanocyte-Stimulating Hormone Protects Retina After Ischemia/Reperfusion Injury in Type I Diabetes. Front Neurosci. 2022 Feb 25;16:799739. doi: 10.3389/fnins.2022.799739. eCollection 2022. PMID: 35281489

  9. Zhou T, Lee A, Lo ACY*, Kwok JSWJ. Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies. Front Pharmacol. 2022 Feb 23;13:816062. doi: 10.3389/fphar.2022.816062. eCollection 2022. PMID: 35281903

  10. Goit RK, Ng TC, Tam KC, Tsang JKW, Taylor AW*, Lo ACY*. Neuropeptide α-Melanocyte-Stimulating Hormone Promotes Neurological Recovery and Repairs Cerebral Ischemia/Reperfusion Injury in Type 1 Diabetes. Neurochem Res. 2022 Feb;47(2):394-408. doi: 10.1007/s11064-021-03453-4. Epub 2021 Sep 29. PMID: 34586586

  11. Yang M, So KF, Lam WC, Lo ACY*. Cell Ferroptosis: New Mechanism and New Hope for Retinitis Pigmentosa. Cells. 2021 Aug 21;10(8):2153. doi: 10.3390/cells10082153. PMID: 34440922

  12. Tang LHC, Fung FKC, Lai AKW, Wong IYH, Shih KC, Lo ACY*. Autophagic Upregulation Is Cytoprotective in Ischemia/Reperfusion-Injured Retina and Retinal Progenitor Cells. Int J Mol Sci. 2021 Aug 6;22(16):8446. doi: 10.3390/ijms22168446. PMID: 34445152

  13. Hu T, Lo ACY*. Collagen-Alginate Composite Hydrogel: Application in Tissue Engineering and Biomedical Sciences. Polymers (Basel). 2021 Jun 2;13(11):1852. doi: 10.3390/polym13111852. PMID: 34199641

  14. Shao Z, Wang Z, Lo ACY, Fu Z: Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases. Front Pharmacol. 2021 Apr 15;12:657684. doi: 10.3389/fphar.2021.657684. eCollection 2021. PMID: 33935774

  15. Tsang JKW, Wolf SA, Pompoes IM, Joussen AM, Lam WC, Yang D, Lo ACY*: Potential Effects of Nutraceuticals in Retinopathy of Prematurity. Life (Basel). 2021 Jan 22;11(2):79. doi: 10.3390/life11020079. PMID: 33499180.

  16. Lai AKW, Ng DTC, Tam BKC, Fung FKC, Chung SK, Lo ACY*: Lutein for alleviating early high mortality and brain pathology after experimental stroke in a genetic type I diabetic mouse model: abridged secondary publication. Hong Kong Med J. 2020 Dec;26 Suppl 7(6):37-41. PMID: 33229618.

  17. Yang M, So KF, Lam WC*, Lo ACY*: Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration? Int J Mol Sci. 2020 Oct 1;21(19):E7279. doi: 10.3390/ijms21197279. Review. PMID: 33019767.

  18. Yang M, Lo ACY*, Lam WC*: Smart phone apps every ophthalmologist should know about. Int J Ophthalmol. 2020 Aug 18;13(8):1329-1333. doi: 10.18240/ijo.2020.08.21. eCollection 2020. PMID: 32821689.

  19. Wang W, Tam KC, Ng TC, Goit RK, Chan KLS, Lo ACY*: Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2Akita/+ mice. BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001519. doi: 10.1136/bmjdrc-2020-001519. PMID: 32665315

  20. Yang M, So KF, Lo ACY*, Lam WC*: The Effect of Lycium barbarum Polysaccharides on Pyroptosis-Associated Amyloid β1-40 Oligomers-Induced Adult Retinal Pigment Epithelium 19 Cell Damage. Int J Mol Sci. 2020 Jun 30;21(13):E4658. doi: 10.3390/ijms21134658. PMID: 32629957.

  21. Li LH, Lee JC, Leung HH, Lam WC, Fu Z, Lo ACY*: Lutein Supplementation for Eye Diseases. Nutrients. 2020 Jun 9;12(6):E1721. doi: 10.3390/nu12061721. Review. PMID: 32526861.

  22. Tsang JKW, Liu J, Lo ACY*: Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity. Int J Mol Sci. 2019 Sep 3;20(17). pii: E4321. doi: 10.3390/ijms20174321. Review. PMID: 31484463.

  23. Wong FSY, Tsang KK, Chu AMW, Chan BP, Yao KM, Lo ACY*: Injectable cell-encapsulating composite alginate-collagen platform with inducible termination switch for safer ocular drug delivery. Biomaterials. 2019 May;201:53-67. doi: 10.1016/j.biomaterials.2019.01.032. Epub 2019 Feb 5. PMID: 30797114.

  24. Wang W, Lo ACY*: Diabetic Retinopathy: Pathophysiology and Treatments. Int J Mol Sci. 2018 Jun 20;19(6):1816. doi: 10.3390/ijms19061816. PMID: 29925789. 25th most cited paper in International Journal of Molecular Sciences (2018)

  25. Yang D, So KF, Lo AC*:  Lycium barbarum polysaccharide extracts preserve retinal function and attenuate inner retinal neuronal damage in a mouse model of transient retinal ischaemia. Clin Exp Ophthalmol. 2017 Sep;45(7):717-729. doi: 10.1111/ceo.12950. Epub 2017 Apr 27. PMID: 28349587.

  26. Fu Z, Meng SS, Burnim SB, Smith LE, Lo AC*: Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity. Clin Exp Ophthalmol. 2017 Jul;45(5):529-538. doi: 10.1111/ceo.12908. Epub 2017 Jan 29. PMID: 28002872.

  27. Wong FSY, Tsang KK, Lo ACY*: Delivery of therapeutics to posterior eye segment: cell-encapsulating systems. Neural Regen Res. 2017 Apr;12(4):576-577. doi: 10.4103/1673-5374.205093. No abstract available. PMID: 28553333.

  28. Fung FK, Law BY, Lo AC*: Lutein Attenuates Both Apoptosis and Autophagy upon Cobalt (II) Chloride-Induced Hypoxia in Rat Műller Cells. PLoS One. 2016 Dec 9;11(12):e0167828. doi: 10.1371/journal.pone.0167828. PMID: 27936094.

  29. Wong FS, Wong CC, Chan BP, Lo AC*: Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model. PLoS One. 2016 Jul 21;11(7):e0159342. doi: 10.1371/journal.pone.0159342. PMID: 27441692

  30. Zheng F, Jang WC, Fung FK, Lo AC*, Wong IY: Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion. PLoS One. 2016 Feb 16;11(2):e0147961. doi: 10.1371/journal.pone.0147961. eCollection 2016. PMID: 26882120

  31. Wong FSY, Lo ACY*: Collagen-Based Scaffolds for Cell Therapies in the Injured Brain. J Stem Cell Res Ther. 2015 5:267. doi: 10.4172/2157-7633.1000267.

  32. Fu Z, Nian S, Li SY, Wong D, Chung SK, Lo AC*: Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1503-13. doi: 10.1007/s00417-015-3024-0. PMID: 25921391.

  33. Liu J, Lai CHY, Lo ACY*: Therapeutic strategies for retinopathy of prematurity. H K J Ophthalmol. 2015 19(1):8-15

  34. Wong FS, Chan BP, Lo AC*: Carriers in cell-based therapies for neurological disorders. Int J Mol Sci. 2014 Jun 13;15(6):10669-723. doi: 10.3390/ijms150610669. Review. PMID: 24933636

  35. Williams RL, Kearns VR, Lo AC*, Day M, Garvey MJ, Krishna Y, Ma D, Stappler T, Wong D: Novel heavy tamponade for vitreoretinal surgery. Invest Ophthalmol Vis Sci. 2013 Nov 5;54(12):7284-92. doi: 10.1167/iovs.13-11876. PMID: 24130181.

  36. Lai AK, Lo AC*: Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res. 2013;2013:106594. doi: 10.1155/2013/106594. Epub 2013 Oct 27. PMID: 24286086. 2nd most cited paper in Journal of Diabetes Research (2013); 2nd most cited author in Journal of Diabetes Research (2013)

  37. Lo ACY*, Lai AKW, Fu ZJ: Stem cell therapy for retinopathy of prematurity. Anat Physiol. 2013;3:126. doi: 10.4172/2161-0940.1000126. Review.

  38. Woo TT, Li SY, Lai WW, Wong D, Lo AC*: Neuroprotective effects of lutein in a rat model of retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):41-51. doi: 10.1007/s00417-012-2128-z. Epub 2012 Aug 18. PMID: 22899456.

  39. Cheung YH, Sheridan CM, Lo AC*, Lai WW: Lectin from Agaricus bisporus inhibited S phase cell population and Akt phosphorylation in human RPE cells. Invest Ophthalmol Vis Sci. 2012 Nov 5;53(12):7469-75. doi: 10.1167/iovs.12-10589. PMID: 23036999.

  40. Li SY, Fu ZJ, Lo AC*: Hypoxia-induced oxidative stress in ischemic retinopathy. Oxid Med Cell Longev. 2012;2012:426769. doi: 10.1155/2012/426769. Epub 2012 Oct 17. Review. PMID: 23125893.

  41. Li SY, Fung FK, Fu ZJ, Wong D, Chan HH, Lo AC*: Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studies. Invest Ophthalmol Vis Sci. 2012 Sep 6;53(10):5976-84. doi: 10.1167/iovs.12-10007. PMID: 22871829.

  42. Fu ZJ, Li SY, Kociok N, Wong D, Chung SK, Lo AC*: Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2012 Aug 20;53(9):5698-712. doi: 10.1167/iovs.12-10122. PMID: 22836764.

  43. Yang D, Li SY, Yeung CM, Chang RCC, So KF, Wong D, Lo AC*: Lycium barbarum extracts protect the brain from blood-brain barrier disruption and cerebral edema in experimental stroke. PLoS One. 2012;7(3):e33596. Epub 2012 Mar 16. PMID: 22438957.

  44. Li SY, Yang D, Fu Z, Woo T, Wong D, Lo AC*: Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke. Neurobiol Dis. 2012 Jan;45(1):624-32. Epub 2011 Oct 17. PMID: 22024715.

  45. Cheung SS, Leung JW, Lam AK, Lam KS, Chung SS, Lo AC*, Chung SK: Selective over-expression of endothelin-1 in endothelial cells exacerbates inner retinal edema and neuronal death in ischemic retina. PLoS One. 2011;6(10):e26184. Epub 2011 Oct 28. PMID: 22053184.

  46. Lo ACY*, Woo TTY, Wong RLM, David Wong D: Apoptosis and other cell death mechanisms after retinal detachment: implications for photoreceptor rescue. Ophthalmologica. 2011;226 suppl 1:10–17. doi: 10.1159/000328206. Epub 2011 Jul 22. Review. PMID: 21778775.

  47. Li SY, Yang D, Yeung CM, Yu WY, Chang RC, So KF, Wong D, Lo AC*: Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury. PLoS One. 2011 Jan 26;6(1):e16380. PMID:21298100.

  48. Li SY, Lo AC*: Lutein protects RGC-5 cells against hypoxia and oxidative stress. Int J Mol Sci. 2010 May 11;11(5):2109-17. PMID: 20559505.

  49. Williams CJ, Lui WC, Li KK, Wong D, Lo AC*: Correspondence. Retina. 2010 Mar;30(3):534-5; author reply 535-6.

  50. Li SY, Fu ZJ, Ma H, Jang WC, So KF, Wong D, and Lo AC*: Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):836-43. Epub 2008 Oct 20. PMID: 18936152.

  51. Lo AC, Cheung AK, Hung VK, Yeung CM, He QY, Chiu JF, Chung SS, Chung SK: Deletion of aldose reductase leads to protection against cerebral ischemic injury. J Cereb Blood Flow Metab. 2007 Aug;27(8):1496-509. Epub 2007 Feb 7. PMID: 17293845.

  52. Lo AC, Chen AY, Hung VK, Yaw LP, Fung MK, Ho MC, Tsang MC, Chung SS, Chung SK: Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J Cereb Blood Flow Metab. 2005 Aug;25(8):998-1011. PMID: 15815585.

  53. Lo AC, Fung MK, Au CL, Chan TS, Sauer B, Chung SS, Chung SK: Transgenic mice over-expressing endothelin-1 in testis transactivated by a Cre/loxP system showed decreased testicular capillary blood flow. Transgenic Res. 2004 Apr;13(2):119-34. PMID: 15198200.

  54. Lo AC, Thinakaran G, Slunt HH, Sisodia SS: Metabolism of the amyloid precursor-like protein-2 (APLP2) in MDCK cells: polarized trafficking occurs independent of the chondroitin sulfate glycosaminoglycan chains.  J Biol Chem. 1995 May 26;270(21):12641-5. PMID: 7759513.

  55. Lo AC, Haass C, Wagner SL, Teplow DB, Sisodia SS: Metabolism of the Swedish amyloid precursor protein variant in Madin-Darby canine kidney (MDCK) cells.  J Biol Chem. 1994 Dec 9;269(49):30966-73. PMID: 7983032.

Selected Research Grant Awards 選定的研究資助獎

(Principal Investigator 首席研究員)

  1. Health and Medical Research Fund (2020) – Preclinical evaluation of extra virgin olive oil and lutein-in-extra-virgin-olive-oil supplementation as a new avenue for prevention of retinopathy of prematurity (Project Reference: 09201116)

  2. General Research Fund (2019/20) - Retinal neurodegeneration and retinal ischemia in diabetic retinopathy – association with autophagy dysfunction (Project Reference: 17112919)

  3. Health and Medical Research Fund (2017) - Terminable cell-encapsulating collagen-alginate composite device for sustained intraocular drug delivery as a therapy for retinal degenerative diseases (Project Reference: 06171516)

  4. Germany/Hong Kong Joint Research Scheme 2017/2018 - Vascular pathophysiology and neuronal dysfunction in gestational diabetes-associated retinopathy of prematurity (Project Reference: G-HKU705/17)

  5. Health and Medical Research Fund (2016) - Beneficial effects of lutein in maternal diabetes-related retinopathy of prematurity using the diabetic Ins2Akita mouse model (Project Reference: 05163526)

  6. Health and Medical Research Fund (2015) - Lutein and candesartan co-treatment delays the progression of non-proliferative diabetic retinopathy in the diabetic Ins2Akita mouse model (Project Reference: 04150746)

  7. Health and Medical Research Fund (2014) - Alleviation of early high mortality and aggravated brain pathology by lutein in a genetic type I diabetic mouse model after experimental stroke (Project Reference: 03142256)

  8. General Research Fund (2013/2014) - Cell-based intraocular delivery of glial-derived neurotrophic factor (GDNF) by collagen-alginate composite gel as a therapy for retinal degenerative diseases (Project Reference: HKU773613M)

  9. General Research Fund (2010/2011) - Neuroprotective effects of lutein in cerebral and retinal ischemia/reperfusion injury: its relation with oxidative stress and post-ischemic inflammation (Project Reference: HKU HKU773210)

  10. Germany/Hong Kong Joint Research Scheme (2009/10) - Oxidative stress, neuronal dysfunction and neovascularization in retinopathy of prematurity (Project Reference: G_HK029/09)

  11. General Research Fund (1997/98) - Targeted over-expression of endothelin-1 in astrocytes as a transgenic model to investigate its role in brain injury and blood-brain barrier function (Project Reference: HKU7240/97M)

Collaborations 合作

  • Prof. Barbara Chan, Department of Mechanical Engineering, The University of Hong Kong

  • Prof. Ying Chau, Department of Chemical and Biomolecular Engineering, School of Engineering, Hong Kong University of Science and Technology

  • Prof. Sookja Chung, Faculty of Medicine, Medicine, Macau University of Science and Technology

  • Prof. Sarah Coupland, Department of Pathology (Ophthalmic Pathology), University of Liverpooll

  • Dr. Zhongjie Fu, Department of Ophthalmology, Harvard University

  • Prof. Antonia Joussen, Department of Ophthalmology, Charité - Universitätsmedizin Berlin

  • Prof. Wai Ching Lam, Department of Ophthalmology, The University of Hong Kong

  • Dr. Jetty Lee, School of Biological Sciences, The University of Hong Kong

  • Dr. Shen Nian, Department of Pathology, Xi’an Medical University

  • Dr. Carl Sheridan, School of Clinical Sciences (Eye and Vision Sciences), University of Liverpool

  • Prof. KF So, Department of Ophthalmology, The University of Hong Kong

  • Dr. Bin Tang, Department of Micro/Nano Materials and Devices, South University of Science and Technology of China, Shenzhen, China

  • Prof. Andrew Taylor, Department of Ophthalmology, Boston University School of Medicine

  • Dr. Weiping Wang, Department of Pharmacology and Pharmacy, The University of Hong Kong

  • Dr. Rachel Williams, Department of Clinical Engineering, University of Liverpool

  • Dr. Di Yang, Department of Ophthalmology, First Affiliated Hospital of Kunming Medical University, Kunming Medical University

  • Dr. Kwok Ming Yao, School of Biomedical Sciences, The University of Hong Kong

Research Laboratories 研究實驗室

Cell-encapsulating Collagen-alginate Composite Device.png

Cell-encapsulating Collagen-alginate Composite Device
細胞封裝膠原-海藻酸鹽複合裝置

Read More 閱讀更多
Retina Biology Lab.png

Retina Biology Lab

視網膜生物學實驗室

​

​

​

Read More 閱讀更多
Retinopathy of Prematurity Lab.png

Retinopathy of Prematurity Lab

早產兒視網膜病變實驗室

​

​

Read More 閱讀更多

ABOUT US

關於我們

We strive for research excellence, professional and public education as well as clinical and community services for empowering positive change of the society.

我們致力於卓越科研、專業和公眾教育，以及臨床及社區服務，以為社會帶來正向的改變。

CONTACT US

聯絡我們

Telephone: +852 3962 1405
Fax: +852 2817 4357

 

Room 301, Level 3,

Block B, Cyberport 4
100 Cyberport Road,

Hong Kong

 

Email: eyeinst@hku.hk

SUBSCRIBE US 訂閱我們

Thanks for submitting. 感謝您提交表單。

  • Facebook
  • Youtube

OPH Staff

Copyright © Department of Ophthalmology. The University of Hong Kong. All Rights Reserved. ©版權屬香港大學眼科所有。

bottom of page